News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Actavis (ACT) To Exit China As Unfriendly Government Not Worth It


1/16/2014 7:39:56 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Actavis Plc (ACT:US), the second-biggest generic drugmaker by market capitalization, said it will end its presence in China because of the difficult business climate.

Help employers find you! Check out all the jobs and post your resume.

Read at Bloomberg
Read at ChinaBio Today

comments powered by Disqus
Actavis
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES